medigraphic.com
Boletín Médico del Hospital Infantil de México

2011, Number 2

<< Back

Bol Med Hosp Infant Mex 2011; 68 (2)

Challenges and progress in the elimination of malaria in Mexico

Betanzos ÁF

Language: Spanish
References: 42
Page: 159-168
PDF size: 445.12 Kb.


ABSTRACT

Malaria continues to be a leading parasite disease in the tropics and subtropics including Latin America. In this region, most cases of malaria are due to Plasmodium vivax, however, cases of Plasmodium falciparum continue to lead to cases of severe malaria in many countries in South America. Control and elimination of malaria in Latin America has been focused on the key steps of the parasite life cycle and transmission mechanism including vector control, decreasing the number of parasites during treatment and human reservoirs with intermittent preventive therapy with antimalarial drugs. In this effort, Mexico has collaborated with many countries in Central America towards the potential elimination of this parasitic infection. In this review, we discuss the achievements and remaining challenges in controlling and potentially eliminating malaria in Mexico.


REFERENCES

  1. Roll Back Malaria (RBM). Roll Back Malaria Partnership. A Global Malaria Action Plan. Geneva: World Health Organization; 2008. Disponible en: http://www.rbm.who.int/gmap/gmap.pdf

  2. World Health Organization (WHO). World Malaria Report 2009. Geneva: World Health Organization; 2009. ISBN 978 92 4 156390 7; WHO/HTM/MAL/GMP/2009.1.

  3. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004;4:327-336.

  4. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-217.

  5. Center for Disease Control (CDC). Malaria during Pregnancy. Atlanta: Centers for Disease Control and Prevention; 2004.

  6. Guerra CA, Snow RW, Hay SI. Mapping the global extent of malaria in 2005. Trends Parasitol 2006;22:353-358.

  7. Guerra CA, Snow RW, Hay SI. Defining the spatial limits of malaria transmission in 2005. Adv Parasitol 2006;62:157-179.

  8. Malaria Control and Community Systems Strengthening Consultation. Malaria control, community systems strengthening and community-owned response. Consensus on best practice for use in the development of Global Fund Round 9 malaria proposals and National Strategy Applications. Geneva: World Vision International; 2009. Disponible en: http://tinyurl.com/yfzabeb

  9. World Health Organization (WHO). Informal consultation on malaria: setting up the WHO agenda. WHO global malaria Program. Geneva: World Health Organization; 2006.

  10. Bruce-Chwatt LJ. Malaria and its control: present situation and future prospects. Annu Rev Public Health 1987;8:75-110.

  11. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001;64(1-2 Suppl):97-106.

  12. Baird JK, Schwartz E, Hoffman SL. Prevention and treatment of vivax malaria. Curr Infect Dis Rep 2007;9:39-46.

  13. Baird JK. Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev 2009;22:508-534.

  14. Castillo CM, Osorio LE, Palma GI. Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a Malaria transmission free area in Colombia. Mem Inst Oswaldo Cruz 2002;97:559-562.

  15. World Health Organization (WHO). WHO guidelines for the treatment of malaria. Geneva: World Health Organization; 2006. WHO/HTM/MAL/2006.1108

  16. Rodriguez MH, Ulloa G, Ramsey JM. Manual para la vigilancia y el control del paludismo en Mesoamérica. Instituto Nacional de Salud Pública. ISBN 978-607-7530-13-8; INSP/México/2008.

  17. Ponçon N, Tran A, Toty C, Luty AJF, Fontenille D. A quantitative risk assessment approach for mosquito-borne diseases: malaria re-emergence in southern France. Malar J 2008;7:147.

  18. Mouchet J, Manguis S, Sircoulon J, Laventure S, Faye O, Onapa AW, et al. Evolution of malaria in Africa for the past 40 years: impact of climatic and human factors. J Am Mosq Control Assoc 1998;14:121-130.

  19. Casimiro SL, Hemingway J, Sharp BL, Coleman M. Monitoring the operational impact of insecticide usage for malaria control on Anopheles funestus from Mozambique. Malar J 2007;6:142.

  20. Pampana E. A Texbook on Malaria Eradication. Oxford: Oxford University Press; 1969.

  21. Pan American Health Organization (PAHO). Health situation in the Americas. Basic indicators 2009. Washington, DC: Pan American Health Organization; 2009.

  22. Franco-Paredes C, Santos-Preciado JI. Prevention of malaria in travelers. Lancet Infect Dis 2006;6:139-149.

  23. Pan American Health Organization (PAHO). Malaria morbidity trend in the Americas. Baseline in 2000; Data for 2006 and 2007; Target for 2010 & 2015 (No. of cases). Washington, DC: Pan American Health Organization; 2008.

  24. World Health Organization (WHO). Everybody’s business - Strengthening health systems to improve outcomes: WHO’s framework for action. Geneva: World Health Organization; 2007.

  25. World Health Organization (WHO). Global malaria control and elimination: report of a technical review. Geneva: World Health Organization; 2008.

  26. Hernández-Ávila JE, Rodríguez MH, Betanzos-Reyes AF, Danis-Lozano R, Méndez-Galván JF, Velázquez-Monroy OJ, et al. Determinant factors for malaria transmission on the coast of Oaxaca State, the main residual transmission focus of Mexico. Salud Publica Mex 2006;48:405-417.

  27. Danis-Lozano R, Rodríguez MH, Betanzos-Reyes AF, Hernández-Ávila JE, González-Cerón L, Méndez-Galván JF, et al. Individual risk factors for Plasmodium vivax infection in the residual malaria transmission focus of Oaxaca, Mexico. Salud Publica Mex 2007;49:199-209.

  28. Rodríguez MH, Betanzos-Reyes AF, Hernández-Ávila JE, Méndez-Galván JF, Danis-Lozano R, Altamirano-Jiménez A. The participation of secondary clinical episodes in the epidemiology of vivax malaria during pre-and post-implementation of focal control in the state of Oaxaca, Mexico. Am J Trop Med Hyg 2009;80:889-895.

  29. Méndez-Galván JF, Betanzos-Reyes AF, Velázquez-Monroy OJ, Tapia Conyer R. Guía para la Implementación y Demostración de Alternativas Sostenibles de Control Integrado de la Malaria en México y América Central. PROYECTO DDT/GEF:UNEP/CENAVECE/SSA/OPS/CCA/GEF. México: Secretaría de Salud; 2004.

  30. Chanon KE, Méndez-Galván JF, Galindo-Jaramillo JM, Olguin-Bernal H, Borja-Aburto VH. Cooperative actions to achieve malaria control without the use of DDT. Int J Hyg Environ Health 2003;206:387-394.

  31. Danis-Lozano R, Rodríguez MH, González-Cerón L, Hernández- Ávila M. Risk factors for Plasmodium vivax infection in the Lacandon forest, southern Mexico. Epidemiol Infect 1999;122:461-469.

  32. Rodríguez-López MH, Loyola-Elizondo EG, Betanzos-Reyes AF, Villarreal-Treviño C, Nielsen-Bown D. Control focal del paludismo: tratamiento focal usando quimioprofilaxis y rociado intradomiciliar con insecticida para el control del paludismo en el sur de México. Gac Med Mex 1994;130:313-319.

  33. Rodríguez AD, Penilla RP, Rodríguez MH, Hemingway J, Betanzos-Reyes AF, Hernández-Ávila JE. Knowledge and beliefs about malaria transmission and practices for vector control in southern Mexico. Salud Publica Mex 2003;45:110-116.

  34. Betanzos-Reyes AF, Rodríguez MH, Duran-Arenas LG, Hernández-Ávila JE, Méndez-Galván JF, Velásquez-Monroy OJ, et al. Comparative analysis of two alternative models for epidemiological surveillance in the Mexican Malaria Control Program. Health Policy 2007;80:465-482.

  35. Instituto Nacional de Salud Pública. Plan Estratégico Mesoamericano para Mejorar el Control de la Malaria hacia su Eliminación. Proyecto de Integración y Desarrollo para Mesoamérica. Cuernavaca, Morelos: Instituto Nacional de Salud Pública; 2010.

  36. Organización Panamericana de la Salud. Manual para líderes y agentes de salud de los pueblos indígenas y afro descendientes. Prevención, vigilancia y control de la malaria. México: Organización Panamericana de la Salud; 2007. Disponible en: http://new.paho.org/hq/dmdocuments/2009/63-manual%20de%20malaria.pdf

  37. Greenwood BM. Control to elimination: implications for malaria research. Trends Parasitol 2008;24:449-454.

  38. Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, et al. Malaria: progress, perils, and prospect for eradication. J Clin Invest 2008;118:1266-1276.

  39. Hay SI, Smith DL, Snow RW. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 2008;8:369-378.

  40. Malaria Elimination Group. Shrinking the Malaria Map: A Guide on Malaria Elimination for Policy Makers. Disponible en: http://www.malariaeliminationgroup.org/

  41. Feachem R, Sabot O. A new global malaria eradication strategy. Lancet 2008;371:1633-1635.

  42. Feachem R, Phillips A, Targett G. Shrinking the Malaria Map. A Prospectus on Malaria Elimination. San Francisco, USA: The Global Health Group; 2009. Disponible en: http://www.malariaeliminationgroup.org/sites/default/files/fileuploads/AProspectusonMalariaElimination.pdf




2020     |     www.medigraphic.com